Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
FiercePharma
12h
Fierce Pharma Asia—Astellas' first-in-class FDA nod; Otsuka's IgAN win; Samsung Bio's $1.2B contract
Astellas' first-in-class CLDN18.2 drug Vyloy has cleared the FDA. After a positive phase 3 readout, Otsuka is targeting an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Grateful Dead bassist dies
DOJ reaches settlement
DNA tests identify skull
Apology for past US policy
Dismissal of charge upheld
ABC News icon Jarriel dies
Kristy now Category 5
CO ballots to be reexamined
MO AG to probe Google
Hit w/ discrimination claims
Browns sue city of Cleveland
New student loan relief plan
SC teen voting glitch
4 astronauts return to Earth
Strike kills 3 journalists
Louisiana forces relocation
Judge blocks $8.5B deal
Murder-for-hire plot arrest
USF basketball coach dies
US mortgage rate climbs
AI firm sued over suicide
Seeks Jan. 6 case dismissal
Exonerated after 22 years
Recalls chicken products
Announces layoffs, jet sales
Phones hacked by China?
E. coli infections rise to 75
Madigan corruption trial
VA voter roll purge blocked
Related topics
Food and Drug Administration
United States
Stomach cancer
Astellas
Feedback